Mark Marriott

2.4k citations

28 papers · 758 indexed · h-index 13

Impact in

Developmental Neuroscience top 2%
- Neurogenesis and neuroplasticity mechanisms
Pathology and Forensic Medicine top 5%
- Multiple Sclerosis Research Studies

Papers in ⓘ

Developmental Neuroscience 3
- Neurogenesis and neuroplasticity mechanisms 3
Pathology and Forensic Medicine 13
- Multiple Sclerosis Research Studies 13

Co-authors: Trevor J. Kilpatrick (17 shared papers)Helmut Butzkueven (15 shared papers)Ben Emery (4 shared papers)Scott Kolbe (7 shared papers)Gary F. Egan (6 shared papers)Anneke van der Walt (7 shared papers)Michele D. Binder (4 shared papers)Holly S. Cate (4 shared papers)
Journals: Glia (4 papers)Multiple Sclerosis and Related Disorders (3 papers)Multiple Sclerosis Journal (2 papers)CNS Drugs (1 paper)PLoS ONE (1 paper)
Partner nations: Australia United States United Kingdom

In The Last Decade

Mark Marriott

27 papers receiving 744 citations

Peers

Countries citing papers authored by Mark Marriott

Since Specialization

Citations

This map shows the geographic impact of Mark Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Marriott more than expected).

Fields of papers citing papers by Mark Marriott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Marriott. The network helps show where Mark Marriott may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Marriott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Marriott Line = papers co-authored together Mark Marriott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians Genes and Immunity ·Justin P. Rubio, Jim Stankovich, Judith Field, Niall Tubridy, Mark Marriott, C. Chapman, Melanie Bahlo, Deshan Perera, LJ Johnson, B. Tait, Michael D. Varney, Terence P. Speed, Bruce Taylor, Simon J. Foote, Helmut Butzkueven, Trevor J. Kilpatrick	2008	97
2	Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss Glia ·Helmut Butzkueven, Ben Emery, Tania Cipriani, Mark Marriott, Trevor J. Kilpatrick	2006	75
3	MRI identification of the rostral‐caudal pattern of pathology within the corpus callosum in the cuprizone mouse model Journal of Magnetic Resonance Imaging ·Qizhu Wu, Qing Yang, Holly S. Cate, Dennis Kemper, Michele D. Binder, Hongxin Wang, Ke Fang, Melissa J. Quick, Mark Marriott, Trevor J. Kilpatrick, Gary F. Egan	2007	72
4	Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination Proceedings of the National Academy of Sciences ·Ben Emery, Holly S. Cate, Mark Marriott, Tobias D. Merson, Michele D. Binder, Cameron Snell, Pik Ying Soo, Simon S. Murray, Ben A. Croker, Jian‐Guo Zhang, Warren S. Alexander, Helen Cooper, Helmut Butzkueven, Trevor J. Kilpatrick	2006	69
5	Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair Glia ·Mark Marriott, Ben Emery, Holly S. Cate, Michele D. Binder, Dennis Kemper, Qizhu Wu, Scott Kolbe, Ian Gordon, Hong Wang, Gary F. Egan, Simon S. Murray, Helmut Butzkueven, Trevor J. Kilpatrick	2008	68
6	A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor Neurology ·Anneke van der Walt, Simon Sung, Timothy Spelman, Mark Marriott, Scott Kolbe, Peter Mitchell, Andrew Evans, Helmut Butzkueven	2012	54
7	Expression of the low‐affinity neurotrophin receptor, p75^NTR, is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination Glia ·Steven Petratos, Michael Gonzales, Michael F. Azari, Mark Marriott, Rebecca A. Minichiello, Kylie Shipham, Christos Profyris, Antonis Nicolaou, Kristy Boyle, Surindar S. Cheema, Trevor J. Kilpatrick	2004	50
8	Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade Pharmacology & Therapeutics ·Anneke van der Walt, Helmut Butzkueven, Scott Kolbe, Mark Marriott, Estella Alexandrou, Melissa Gresle, Gary F. Egan, Trevor J. Kilpatrick	2010	47
9	Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis Human Genetics ·Justin P. Rubio, Niall Tubridy, Melanie Bahlo, Jim Stankovich, Rachel K. Burfoot, Helmut Butzkueven, Caron Chapman, Laura Johnson, Mark Marriott, Grant Mraz, Brian D. Tait, Chris Wilkinson, Bruce Taylor, Terence P. Speed, Simon J. Foote, Trevor J. Kilpatrick	2004	41
10	Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes PLoS ONE ·Anneke van der Walt, Scott Kolbe, Yejun E. Wang, Alexander Klistorner, Neil Shuey, Gelareh Ahmadi, Mark Paine, Mark Marriott, Peter Mitchell, Gary F. Egan, Helmut Butzkueven, Trevor J. Kilpatrick	2013	41
11	Diffusion Tensor Imaging Correlates of Visual Impairment in Multiple Sclerosis and Chronic Optic Neuritis Investigative Ophthalmology & Visual Science ·Scott Kolbe, Mark Marriott, Anneke van der Walt, Joanne Fielding, Alexander Klistorner, Peter Mitchell, Helmut Butzkueven, Trevor J. Kilpatrick, Gary F. Egan	2012	33
12	Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study CNS Drugs ·Nabil Seery, Sifat Sharmin, Vivien Li, Ai‐Lan Nguyen, Claire Meaton, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John P. Carey, Mark Marriott, Katherine Buzzard, Izanne Roos, Chris Dwyer, Josephine Baker, Lisa Taylor, Kymble Spriggs, Trevor J. Kilpatrick, Tomáš Kalinčík, Mastura Monif	2021	30
13	Remote Sensing of Vital Signs: A Wearable, Wireless “Band-Aid” Sensor With Personalized Analytics for Improved Ebola Patient Care and Worker Safety Global Health Science and Practice ·Steven R. Steinhubl, Mark Marriott, Stephan Wegerich	2015	16
14	Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor Glia ·Melissa Gresle, Helmut Butzkueven, Victoria M. Perreau, Anna Jonas, Junhua Xiao, Stefan Thiem, Fiona E. Holmes, William O.S. Doherty, Pik‐Ying Soo, Michele D. Binder, Rainer Akkermann, Vilija Jokubaitis, Holly S. Cate, Mark Marriott, Andrew L. Gundlach, David Wynick, Trevor J. Kilpatrick	2015	12
15	Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic Multiple Sclerosis and Related Disorders ·Vivien Li, Izanne Roos, Mastura Monif, Charles B. Malpas, Stefanie Roberts, Mark Marriott, Katherine Buzzard, Ai‐Lan Nguyen, Nabil Seery, Lisa Taylor, Tomáš Kalinčík, Trevor J. Kilpatrick	2022	9
16	Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia Multiple Sclerosis and Related Disorders ·Nabil Seery, Vivien Li, Ai‐Lan Nguyen, Izanne Roos, Katherine Buzzard, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John P. Carey, Chris Dwyer, Hasini Fernandoa Lisa Taylor, Josephine Baker, Mark Marriott, Trevor J. Kilpatrick, Tomáš Kalinčík, Mastura Monif	2020	8
17	Neutropaenia complications from Ocrelizumab and Rituximab treatment Multiple Sclerosis and Related Disorders ·Venus Pang, Nabil Seery, Robb Wesselingh, Wei Zhen Yeh, Michael Zhong, Tracie Tan, Chris Dwyer, Cassie Nesbitt, Louise Rath, D. I. Perera, Francesca Bridge, Olga Skibina, Julian J. Bosco, Vilija Jokubaitis, Mark Marriott, Helmut Butkueven, Anneke van der Walt, Jennifer Massey, Ian Sutton, Mastura Monif	2023	8
18	The occurrence of dystonia in upper-limb multiple sclerosis tremor Multiple Sclerosis Journal ·Anneke van der Walt, Katherine Buzzard, Sarah Sung, Tim Spelman, Scott Kolbe, Mark Marriott, Helmut Butzkueven, Andrew Evans	2015	7
19	Failure of alemtuzumab therapy in three patients with MOG antibody associated disease BMC Neurology ·Sinali O. Seneviratne, Mark Marriott, Sudarshini Ramanathan, Wei Zhen Yeh, Fabienne Brilot‐Turville, Helmut Butzkueven, Mastura Monif	2022	5
20	PDF417 portable data files a new dimension in barcodes Sensor Review ·Mark Marriott	1995	4

About Mark Marriott

Mark Marriott is a scholar working on Developmental Neuroscience, Pathology and Forensic Medicine, Neurology, Ophthalmology and Immunology, having authored 28 papers that have together received 758 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Reproductive System and Pregnancy (4 papers), Advanced Neuroimaging Techniques and Applications (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Hereditary Neurological Disorders (2 papers). The work is most often cited by research in Developmental Neuroscience (184 citations), Pathology and Forensic Medicine (296 citations), Neurology (102 citations), Immunology (207 citations) and Neurology (133 citations). Mark Marriott has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Trevor J. Kilpatrick, Helmut Butzkueven, Ben Emery, Scott Kolbe, Gary F. Egan, Anneke van der Walt, Michele D. Binder, Holly S. Cate, Peter Mitchell and Qizhu Wu. Their work appears in journals such as Glia, Multiple Sclerosis and Related Disorders, Multiple Sclerosis Journal, CNS Drugs and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact